Naminidil
|
N646738-100mg
|
≥99% |
220641-11-2 |
100mg
|
¥ 11250.9
|
期货,请咨询 |
阿拉丁 |
N-Ethylmaleimide-d5
|
N646728-5mg
|
≥99% |
360768-37-2 |
5mg
|
¥ 5350.9
|
期货,请咨询 |
阿拉丁 |
N-Ethylmaleimide-d5
|
N646728-1mg
|
≥99% |
360768-37-2 |
1mg
|
¥ 1900.9
|
期货,请咨询 |
阿拉丁 |
N-Ethylmaleimide-d5
|
N646728-10mg
|
≥99% |
360768-37-2 |
10mg
|
¥ 8600.9
|
期货,请咨询 |
阿拉丁 |
NCT-505
|
N646703-5mg
|
≥98% |
2231079-74-4 |
5mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
NCT-505
|
N646703-1mg
|
≥98% |
2231079-74-4 |
1mg
|
¥ 1904.9
|
期货,请咨询 |
阿拉丁 |
NCT-505
|
N646703-10mg
|
≥98% |
2231079-74-4 |
10mg
|
¥ 8200.9
|
期货,请咨询 |
阿拉丁 |
NIM811
|
N646687-5mg
|
≥99% |
143205-42-9 |
5mg
|
¥ 9900.9
|
期货,请咨询 |
阿拉丁 |
NIM811
|
N646687-1mg
|
≥99% |
143205-42-9 |
1mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
NBI-98782
|
N646649-5mg
|
≥98% |
85081-18-1 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
NBI-98782
|
N646649-50mg
|
≥98% |
85081-18-1 |
50mg
|
¥ 13000.9
|
期货,请咨询 |
阿拉丁 |
NBI-98782
|
N646649-25mg
|
≥98% |
85081-18-1 |
25mg
|
¥ 7700.9
|
期货,请咨询 |
阿拉丁 |
NBI-98782
|
N646649-1mg
|
≥98% |
85081-18-1 |
1mg
|
¥ 1142.9
|
期货,请咨询 |
阿拉丁 |
NBI-98782
|
N646649-10mg
|
≥98% |
85081-18-1 |
10mg
|
¥ 4300.9
|
期货,请咨询 |
阿拉丁 |
Neuropeptide Y (13-36), amide, human
|
N646628-5mg
|
≥98% |
122341-40-6 |
5mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
Neuropeptide Y (13-36), amide, human
|
N646628-500μg
|
≥98% |
122341-40-6 |
500μg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Neuropeptide Y (13-36), amide, human
|
N646628-1mg
|
≥98% |
122341-40-6 |
1mg
|
¥ 2600.9
|
期货,请咨询 |
阿拉丁 |
NSC-370284
|
N646601-5mg
|
≥96% |
116409-29-1 |
5mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
NSC-370284
|
N646601-50mg
|
≥96% |
116409-29-1 |
50mg
|
¥ 5400.9
|
期货,请咨询 |
阿拉丁 |
NSC-370284
|
N646601-25mg
|
≥96% |
116409-29-1 |
25mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
NSC-370284
|
N646601-10mg
|
≥96% |
116409-29-1 |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
NSC-370284
|
N646601-100mg
|
≥96% |
116409-29-1 |
100mg
|
¥ 9400.9
|
期货,请咨询 |
阿拉丁 |
Neocarzinostatin
|
N646600-100μg
|
|
9014-02-2 |
100μg
|
¥ 17000.9
|
期货,请咨询 |
阿拉丁 |
Nav1.7 inhibitor
|
N646570-5mg
|
≥99% |
1355631-24-1 |
5mg
|
¥ 3255.9
|
期货,请咨询 |
阿拉丁 |